← Open Payments lookup

GUILLERMO GONZALEZ: Open Payments

NPI 1720839798 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,391 in 89 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $772 · 2025 $1,391

Food & beverage: $1,281Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.24$424
ABBVIE INC.23$260
Neurocrine BioSciences, Inc.15$183
Janssen Pharmaceuticals, Inc6$146
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$140
Alkermes, Inc.4$68
Vanda Pharmaceuticals Inc.3$55
E.R. Squibb & Sons, L.L.C.3$52
Otsuka America Pharmaceutical, Inc.2$34
Luye Pharma (USA) Ltd.1$15

Products named: UZEDY, VRAYLAR, INGREZZA, INVEGA SUSTENNA, CAPLYTA, FANAPT, ARISTADA, COBENFY.

Industry payments across TX — which companies pay providers there.